Pneumococcal Vaccine Market to see Huge Growth by 2029

The global pneumococcal vaccine market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market includes the increasing efforts to curb pneumonia among children in developed countries. Whereas, in the developing countries, the increasing spending on infrastructure and rising awareness towards vaccines, are the factors, which are expected to fuel the market growth during the forecasted period.

According to the report by Jon Hopkins, in 2019, 5 million children died before reaching the age of 5 years, out of which around 25% of children died due to pneumonia or diarrhoea. The developing countries in Asia and Africa contribute to around 70% of the global death burden of children due to pneumonia. GAVI (the vaccine alliance) is working towards vaccinating these children who are living in emerging economies. For many countries including the UK, Canada, Russia, Norway, Bill Gates and Melinda Gates Foundation had contributed around $1.5 billion towards the program. By the end of 2018, more than 183 million children were given shot of the vaccine against pneumococcal.

Some of the key global market players include Pfizer Inc., Sanofi SA, GlaxoSmithKline PLC, Serum Institute of India Pvt. Ltd., Merck & Co., Inc., Walvax Biotechnology Co., Ltd., CSL Ltd., and Astellas Pharma Inc. In June 2020, the Serum Institute of India started supplying vaccines for $2 as compared to $3.5 per dose earlier. The company had agreed to provide 10 million doses per year to the countries which are supported by GAVI for the next 10 years.

To Request a Sample of our Report on Pneumococcal Vaccine Market:https://www.omrglobal.com/request-sample/pneumococcal-vaccine-market

Pneumococcal Vaccine Market- Segmentation

By Vaccine Type

Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
Others
By Distribution Channel

Public
Private
By Type

Branded
Generic
By Age Group

Children
Adult
A full report of Pneumococcal Vaccine Market is available at: https://www.omrglobal.com/industry-reports/pneumococcal-vaccine-market

Pneumococcal Vaccine Market- Segment by Region

North America

United States
Canada
Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific

China
Japan
India
Rest of Asia-Pacific
Rest of the World

Middle East & Africa
Latin America
Company Profiles

Astellas Pharma Inc.
China National Biotec Group Company Ltd.
CSL Ltd.
GlaxoSmithKline PLC
Merck & Co., Inc.
Novavax, Inc.
Pfizer Inc.
Walvax Biotechnology Co., Ltd.
SK Bioscience
Sanofi SA
Serum Institute of India Pvt. Ltd.
PnuVax Incorporated
Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.